Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Kroeger, Cynthia M ^a   Klempel, Monica C ^a   Bhutani, Surabhi ^a   Trepanowski, John F ^a   Tangney, Christine C ^b   Varady, Krista A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

Body weight; Calorie restriction; Cholesterol; Coronary heart disease; Intermittent fasting; Liquid diet; Obese women; Visceral fat

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY COMPOSITION; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; HUMAN; INTERMITTENT FASTING; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; OBESITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE;

EID: 84868254826     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-98     Document Type: Article

References (24)

1. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. Mattson MP, Wan R, J Nutr Biochem 2005 16 3 129 137 10.1016/j.jnutbio.2004.12.007 15741046 (Pubitemid 40312164)
2. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al. Int J Obes (Lond) 2011 35 5 714 727 10.1038/ijo.2010.171
3. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Williams KV, Mullen ML, Kelley DE, Wing RR, Diabetes Care 1998 21 1 2 8 10.2337/diacare.21.1.2 9538962 (Pubitemid 28030377)
4. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI, Int J Obes Relat Metab Disord 2003 27 5 537 549 10.1038/sj.ijo.0802258 12704397 (Pubitemid 36561010)
5. The evolution of very-low-calorie diets: an update and meta-analysis. Tsai AG, Wadden TA, Obesity (Silver Spring) 2006 14 8 1283 1293 10.1038/oby.2006.146 (Pubitemid 46219653)
6. Adipokines and the cardiovascular system: mechanisms mediating health and disease. Northcott JM, Yeganeh A, Taylor CG, Zahradka P, Wigle JT, Can J Physiol Pharmacol 2012 90 8 1029 1059 10.1139/y2012-053 22646022
7. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ, J Clin Invest 2001 108 10 1533 1540 11714745 (Pubitemid 33091991)
8. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Goetze S, Bungenstock A, Czupalla C, Eilers F, Stawowy P, Kintscher U, et al. Hypertension 2002 40 5 748 754 10.1161/01.HYP.0000035522. 63647.D3 12411472 (Pubitemid 35278614)
9. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V, Thromb Haemost 2006 95 3 511 518 16525580
10. Inflammatory markers in coronary heart disease. Madjid M, Willerson JT, Br Med Bull 2011 100 23 38 10.1093/bmb/ldr043 22010105
11. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal I, J Lipid Res 2008 49 5 1015 1023 10.1194/jlr.M700535-JLR200 18245817
12. Associations of isoprostanes-related oxidative stress with surrogate subclinical indices and angiographic measures of atherosclerosis. Basarici I, Altekin RE, Demir I, Yilmaz H, Coron Artery Dis 2007 18 8 615 620 10.1097/MCA.0b013e3282f0efa5 18004111 (Pubitemid 351339514)
13. Smooth muscle cell phenotypes in atherosclerotic lesions. Shanahan CM, Weissberg PL, Curr Opin Lipidol 1999 10 6 507 513 10.1097/00041433-199912000- 00005 10680044 (Pubitemid 30064020)
14. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Matsuzawa Y, Funahashi T, Nakamura T, J Atheroscler Thromb 2011 18 8 629 639 10.5551/jat.7922 21737960
15. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S, Diabetes 2007 56 4 1010 1013 10.2337/db06-1656 17287468 (Pubitemid 46525079)
16. A new predictive equation for resting energy expenditure in healthy individuals. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO, Am J Clin Nutr 1990 51 2 241 247 2305711
17. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al. Clin Chem 2001 47 2 266 274 11159775 (Pubitemid 32142925)
18. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss. Poynten AM, Markovic TP, Maclean EL, Furler SM, Freund J, Chisholm DJ, et al. Int J Obes Relat Metab Disord 2003 27 10 1212 1218 10.1038/sj.ijo.0802393 14513069 (Pubitemid 37281669)
19. Effects of acute caloric restriction on cholesterol metabolism in man. Kudchodkar BJ, Sodhi HS, Mason DT, Borhani NO, Am J Clin Nutr 1977 30 7 1135 1146 879078 (Pubitemid 8151702)
20. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Rodriguez A, Catalan V, Gomez-Ambrosi J, Fruhbeck G, Curr Pharm Des 2007 13 21 2169 2175 17627548 (Pubitemid 47074048)
21. Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. Klempel MC, Varady KA, Nutr Rev 2011 69 3 145 154 10.1111/j.1753-4887.2011.00373.x 21348878
22. The effect of weight loss magnitude on pro/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight-loss therapy. Masquio DC, de Piano A, Sanches PL, Corgosinho FC, Campos RM, Carnier J, et al. Clin Endocrinol (Oxf) 2012
23. Leptin: an essential regulator of lipid metabolism. Reidy SP, Weber J, Comp Biochem Physiol A Mol Integr Physiol 2000 125 3 285 298 10.1016/S1095-6433(00)00159-8 10794958 (Pubitemid 30224797)
24. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Feingold KR, Adi S, Staprans I, Moser AH, Neese R, Verdier JA, et al. Am J Physiol 1990 259 2 Pt 1 177 E184 2382712